Effects of amlodipine: A Synthesis of Findings from 37 Studies
- Home
- Effects of amlodipine
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of amlodipine: A Synthesis of Findings from 37 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Amlodipine is a calcium channel blocker used to treat high blood pressure and stable angina. A meta-analysis in 36 found that amlodipine has three times higher risk of peripheral edema compared to placebo. However, it is estimated that up to one-third of edema cases in amlodipine-treated patients are not induced by the drug itself. Amlodipine was also found to reduce the occurrence of headaches compared to placebo, especially at low to medium doses (2.5-5 mg). 16 demonstrated that amlodipine does not increase the risk of arrhythmias in patients with severe, chronic coronary artery disease who are already receiving conventional anti-ischemic therapy. 26 reported that amlodipine in combination with perindopril had a lower incidence of cardiovascular events and diabetes compared to atenolol and bendroflumethiazide. 17 showed that amlodipine significantly reduces the number of ischemic events in patients with stable angina pectoris during daily life. 35 suggests that amlodipine may alter hemorheological parameters. 19 found that amlodipine may slow down the progression of atherosclerosis. 14 reported that amlodipine had a significantly greater reduction in blood pressure than long-acting diltiazem. 8 showed that amlodipine is safe and effective for the treatment of chronic stable angina pectoris. A meta-analysis in 33 found that amlodipine significantly reduced the risk of myocardial infarction and stroke compared to other non-CCB antihypertensive therapies. 6 showed that amlodipine was comparable to hydrochlorothiazide in reducing blood pressure. 23 found that amlodipine combined with benazepril had a significantly higher blood pressure reduction compared to amlodipine monotherapy. 12 showed that amlodipine is effective and well-tolerated in patients with stable angina. 2 reported that amlodipine was more effective and tolerated compared to nifedipine in treating chronic ischemic heart disease. 28 reported that both amlodipine and telmisartan, and amlodipine and amiloride, are effective combinations for blood pressure control in hypertensive patients. 3 found that amlodipine was associated with a lower incidence of acute side effects compared to nitrendipine. 30 reported that bedtime dosing of amlodipine combined with valsartan showed the highest blood pressure control effect. 11 showed that amlodipine is comparable to hydrochlorothiazide in reducing blood pressure and is well-tolerated. 13 reported that amlodipine was associated with fewer early side effects compared to nifedipine. 4 showed that amlodipine is effective and well-tolerated in treating stable angina pectoris. 5 found that amlodipine was comparable to atenolol in reducing blood pressure, but without affecting heart rate. 7 showed that amlodipine is effective and well-tolerated in treating mild to moderate hypertension. 9 reported that amlodipine was comparable to enalapril in terms of efficacy and tolerability. 27 reported that amlodipine combined with atorvastatin was superior to monotherapy in improving vascular and metabolic effects in hypertensive patients. 21 found that amlodipine is effective in treating isolated systolic hypertension in elderly patients. 22 showed that amlodipine significantly reduces 24-hour ambulatory blood pressure in hypertensive patients. 15 showed that amlodipine was not significantly better than placebo in reducing ambulatory ischemia in patients with stable angina who are already receiving beta-blockers. 1 showed that amlodipine is effective in controlling blood pressure for the entire dosing interval with a once-daily dose. 20 found that amlodipine has a good tolerability profile in elderly hypertensives. 25 found that amlodipine combined with atorvastatin resulted in early improvements in arterial wall compliance in hypertensive patients with dyslipidemia. 37 showed that amlodipine is well tolerated and has a favorable safety profile in healthy Chinese volunteers. 32 reported that amlodipine combined with azilsartan medoxomil was well tolerated and led to meaningful additional blood pressure reductions compared with placebo plus amlodipine. 18 showed that amlodipine can improve exercise tolerance in patients with heart failure from left ventricular systolic dysfunction. 34 suggested that combining perindopril arginine and amlodipine besylate in a single pill may be a useful addition to the antihypertensive armamentarium. 29 showed that the triple combination of amlodipine, valsartan, and hydrochlorothiazide was more effective in lowering blood pressure than dual-component therapies. 24 found that amlodipine camsylate and amlodipine besylate are comparable in their effectiveness in treating hypertension in Korean adults. 10 showed that amlodipine is effective in reducing ischemia in patients with stable angina pectoris who are already receiving beta-blockers. 31 suggests that both amlodipine and S(-)-amlodipine are effective in improving vascular endothelial function in hypertensive patients.
Benefits and Risks
Benefits Summary
Amlodipine is a medication effective for treating high blood pressure and stable angina. Multiple studies have shown that amlodipine effectively lowers blood pressure and reduces the risk of myocardial infarction and stroke. 33 Amlodipine is also expected to improve exercise tolerance in patients with stable angina. 17 Additionally, amlodipine has been shown to improve endothelial function and may slow down the progression of atherosclerosis. 19 25 Furthermore, amlodipine can be used in combination with other antihypertensive medications to potentially achieve better blood pressure control. 32 28 23 Amlodipine is generally well-tolerated and considered safe for many patients. 8 9 37
Risks Summary
A possible side effect of amlodipine is peripheral edema. 36 There are also reports indicating that amlodipine may increase the risk of heart failure. 33 Amlodipine can interact with other medications, so it is crucial to consult with a doctor before taking it.
Comparison between Studies
Commonalities between Studies
Many studies have shown that amlodipine is effective in treating high blood pressure and stable angina. Additionally, most studies have reported that amlodipine is generally well-tolerated and safe.
Differences between Studies
The blood pressure reduction effect of amlodipine may be more pronounced when combined with other antihypertensive medications. 23 32 The time of day amlodipine is taken may also influence its blood pressure control effect. 30 The effectiveness of amlodipine can vary depending on individual patient characteristics and interactions with other medications.
Consistency and Discrepancies in Results
Although many studies have shown amlodipine to be effective in treating high blood pressure and stable angina, there are reports suggesting that it may increase the risk of heart failure. 33 Further research is needed to investigate this discrepancy.
Practical Implications and Precautions
It is crucial to take amlodipine as directed by your doctor. Do not stop or change the dosage without consulting your doctor. Be aware of possible side effects such as peripheral edema and heart failure. 36 33 Additionally, be mindful of potential interactions with other medications. Consult your doctor before taking amlodipine.
Limitations of Current Research
While there is a wealth of research on the effects of amlodipine, some aspects remain unclear. For example, the evidence suggesting that amlodipine increases the risk of heart failure is not yet conclusive. 33 The effectiveness of amlodipine can also vary depending on individual patient characteristics and interactions with other medications.
Future Directions for Research
Further research is needed to better understand the effects of amlodipine. Specifically, it is essential to investigate whether amlodipine indeed increases the risk of heart failure and to understand the mechanisms involved. Additionally, more detailed research is required to determine how the effects of amlodipine vary depending on individual patient characteristics and interactions with other medications.
Conclusion
Amlodipine is an effective medication for treating high blood pressure and stable angina and is considered safe for many patients. However, it is important to be aware of possible side effects such as peripheral edema and heart failure. 36 33 Consult with your doctor before taking amlodipine and adhere to their instructions for proper use.
Benefit Keywords
Risk Keywords
Article Type
Author: BroadhurstP, HeberM E, BrigdenG, al-KhawajaI, RafteryE B
Language : English
Author: CircoA, ScaccianoceG, PlataniaF, CastelliD, CardilloR, MangiameliS
Language : English
Author: WaeberB, BorgesE T, ChristelerP, Guillaume-GentilM, HollensteinU, MannhartM
Language : English
Author: CoccoG, AlfieroR
Language : English
Author: de BruijnB, CoccoG, TylerH M
Language : English
Author: RofmanB A
Language : English
Author: WebsterJ, RobbO J, JeffersT A, ScottA K, PetrieJ C, TowlerH M
Language : English
Author: GlasserS P, WestT W
Language : English
Author: OmvikP, ThaulowE, HerlandO B, EideI, MidhaR, TurnerR R
Language : English
Author: LehmannG, ReinigerG, BeyerleA, RudolphW
Language : English
Author: RamC V, AmesR P, ApplegateW B, BurrisJ F, DavidovM E, MroczekW J
Language : English
Author: DeedwaniaP C, CheitlinM D, DasS K, PoolP E, SinghJ B, PasternakR C
Language : English
Author: BremnerA D, FellP J, HosieJ, JamesI G, SaulP A, TaylorS H
Language : English
Author: HorwitzL D, WeinbergerH D, CleggL
Language : English
Author: RossinenJ, PartanenJ, NieminenM S
Language : English
Author: LichtlenP R, FisherL D
Language : English
Author: DeedwaniaP C
Language : English
Author: UdelsonJ E, DeAbateC A, BerkM, NeubergG, PackerM, VijayN K, GorwittJ, SmithW B, KukinM L, LeJemtelT, LevineT B, KonstamM A
Language : English
Author: ZannadF
Language : French
Author: LeonettiGastone, MagnaniBruno, PessinaAchille Cesare, RappelliAlessandro, TrimarcoBruno, ZanchettiAlberto,
Language : English
Author: MalaccoEttore, VarìNatale, CapuanoVincenzo, SpagnuoloVitaliano, BorgninoCarlo, PalatiniPaolo,
Language : English
Language : English
Author: ChrysantSteven G, SugimotoDaniel H, LefkowitzMarty, SalkoThomas, KhanMahmudul, AroraVipin, ShiVictor
Language : English
Author: KimSang-Hyun, KimYoung-Dae, LimDo-Sun, YoonMyeong-Ho, AhnYoung-Keun, OnYoung-Keun, LeeJe-Won, KimIn-Jae, ParkJung-Bae, KimJae-Joong, ChungWook-Sung, YangJu-Young, SeoHong-Seok, ShinEak-Kyun, KimHyo-Soo,
Language : English
Author: CohnJay N, WilsonDaniel J, NeutelJoel, HoustonMark, WeinbergerMyron H, GrimmRichard, SmithDavid H G, SunWilliam
Language : English
Author: KohKwang Kon, QuonMichael J, HanSeung Hwan, LeeYonghee, KimSoo Jin, KohYesl, ShinEak Kyun
Language : English
Author: KohKwang Kon, QuonMichael J, HanSeung Hwan, LeeYonghee, ParkJeong Beom, KimSoo Jin, KohYesl, ShinEak Kyun
Language : English
Author: WangWen, MaLi-yuan, LiuMing-bo, DengQing, ZhangYu-qing, LiWei, ZhuDing-liang, LinShu-guang, HuangJun, LiuLi-sheng,
Language : Chinese
Author: CalhounDavid A, CrikelairNora A, YenJoseph, GlazerRobert D
Language : English
Author: HermidaRamón C, AyalaDiana E, FontaoMaría J, MojónArtemio, FernándezJosé R
Language : English
Author: HeYuquan, SiDaoyuan, YangChunyan, NiLujia, LiBing, DingMei, YangPing
Language : English
Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension.
Author: WeberMichael A, WhiteWilliam B, SicaDomenic, BakrisGeorge L, CaoCharlie, RobertsAndrew, KupferStuart
Language : English
Author: LeeSeung-Ah, ChoiHong-Mi, ParkHye-Jin, KoSu-Kyoung, LeeHae-Young
Language : English
Author: ElliottWilliam J
Language : English
Author: RavindraR P, ArunkumarS, PuniyaniR R, PadgaonkarK, VadiveluRamalingam, SharmaRajeev, PanickerGopi, LokhandwalaYash
Language : English
Author: VukadinovićDavor, ScholzSean S, MesserliFranz H, WeberMichael A, WilliamsBryan, BöhmMichael, MahfoudFelix
Language : English
Author: WangTongtong, WangYannan, LinSisi, FangLu, LouSai, ZhaoDi, ZhuJingjing, YangQigang, WangYing
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.